PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CC vs. IOSP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CC and IOSP is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

CC vs. IOSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Chemours Company (CC) and Innospec Inc. (IOSP). The values are adjusted to include any dividend payments, if applicable.

-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%5.00%AugustSeptemberOctoberNovemberDecember2025
-16.97%
-10.25%
CC
IOSP

Key characteristics

Sharpe Ratio

CC:

-0.49

IOSP:

0.02

Sortino Ratio

CC:

-0.34

IOSP:

0.23

Omega Ratio

CC:

0.95

IOSP:

1.03

Calmar Ratio

CC:

-0.48

IOSP:

0.02

Martin Ratio

CC:

-1.00

IOSP:

0.05

Ulcer Index

CC:

29.82%

IOSP:

10.19%

Daily Std Dev

CC:

60.91%

IOSP:

28.28%

Max Drawdown

CC:

-86.15%

IOSP:

-91.17%

Current Drawdown

CC:

-55.43%

IOSP:

-12.30%

Fundamentals

Market Cap

CC:

$2.90B

IOSP:

$2.86B

EPS

CC:

$0.51

IOSP:

$5.82

PE Ratio

CC:

38.04

IOSP:

19.67

PEG Ratio

CC:

1.67

IOSP:

-2.95

Total Revenue (TTM)

CC:

$4.39B

IOSP:

$1.38B

Gross Profit (TTM)

CC:

$879.00M

IOSP:

$406.70M

EBITDA (TTM)

CC:

$519.00M

IOSP:

$174.00M

Returns By Period

In the year-to-date period, CC achieves a 14.79% return, which is significantly higher than IOSP's 4.01% return.


CC

YTD

14.79%

1M

9.48%

6M

-16.97%

1Y

-30.62%

5Y*

7.91%

10Y*

N/A

IOSP

YTD

4.01%

1M

4.85%

6M

-8.82%

1Y

-1.46%

5Y*

2.86%

10Y*

11.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CC vs. IOSP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CC
The Risk-Adjusted Performance Rank of CC is 2121
Overall Rank
The Sharpe Ratio Rank of CC is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of CC is 2323
Sortino Ratio Rank
The Omega Ratio Rank of CC is 2222
Omega Ratio Rank
The Calmar Ratio Rank of CC is 1818
Calmar Ratio Rank
The Martin Ratio Rank of CC is 2323
Martin Ratio Rank

IOSP
The Risk-Adjusted Performance Rank of IOSP is 4343
Overall Rank
The Sharpe Ratio Rank of IOSP is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of IOSP is 3838
Sortino Ratio Rank
The Omega Ratio Rank of IOSP is 3838
Omega Ratio Rank
The Calmar Ratio Rank of IOSP is 4646
Calmar Ratio Rank
The Martin Ratio Rank of IOSP is 4646
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CC vs. IOSP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Chemours Company (CC) and Innospec Inc. (IOSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CC, currently valued at -0.49, compared to the broader market-2.000.002.004.00-0.490.02
The chart of Sortino ratio for CC, currently valued at -0.34, compared to the broader market-4.00-2.000.002.004.006.00-0.340.23
The chart of Omega ratio for CC, currently valued at 0.95, compared to the broader market0.501.001.502.000.951.03
The chart of Calmar ratio for CC, currently valued at -0.48, compared to the broader market0.002.004.006.00-0.480.02
The chart of Martin ratio for CC, currently valued at -1.00, compared to the broader market-10.000.0010.0020.0030.00-1.000.05
CC
IOSP

The current CC Sharpe Ratio is -0.49, which is lower than the IOSP Sharpe Ratio of 0.02. The chart below compares the historical Sharpe Ratios of CC and IOSP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.49
0.02
CC
IOSP

Dividends

CC vs. IOSP - Dividend Comparison

CC's dividend yield for the trailing twelve months is around 5.15%, more than IOSP's 1.35% yield.


TTM20242023202220212020201920182017201620152014
CC
The Chemours Company
5.15%5.92%3.17%3.27%2.98%4.03%5.53%2.98%0.24%0.54%10.82%0.00%
IOSP
Innospec Inc.
1.35%1.41%1.14%1.24%1.28%1.15%0.99%1.44%1.09%0.98%1.12%1.29%

Drawdowns

CC vs. IOSP - Drawdown Comparison

The maximum CC drawdown since its inception was -86.15%, smaller than the maximum IOSP drawdown of -91.17%. Use the drawdown chart below to compare losses from any high point for CC and IOSP. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-55.43%
-12.30%
CC
IOSP

Volatility

CC vs. IOSP - Volatility Comparison

The Chemours Company (CC) has a higher volatility of 14.43% compared to Innospec Inc. (IOSP) at 7.57%. This indicates that CC's price experiences larger fluctuations and is considered to be riskier than IOSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
14.43%
7.57%
CC
IOSP

Financials

CC vs. IOSP - Financials Comparison

This section allows you to compare key financial metrics between The Chemours Company and Innospec Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab